"We need many more people interested in the problem and applying for research dollars. As Vicky said, we fund the best science. If applications come in… in fact ME/CFS is a very high priority for us. If there were meritorious applications to fund we would fund them. If Nancy were here she will tell you the challenge in peer review of these applications— I have to tell you they’re all not that great. You wouldn’t want us to fund those applications. We want to fund the best that will benefit you.
And so that’s the challenge for us. We get very few per year. Just throwing money out there will not get people to ...sometimes they suddenly get interested, but they have to be poised and ready to go with a good idea and a good methodology to do it. It’s not that we won’t fund it, we would if there were applications there -- and meritorious, that pass peer review. I hope that helps you understand."
Platitudes from the NIH.
We are stuck in a catch-22 researchers are sitting on the sidelines waiting for the next 'big breakthrough', before they are willing to dip their toes in. Meanwhile, very few researchers are submitting applications and getting funding - because they are afraid of wasting their time due to an extremely high rate of being knocked back.
We need to encourage a specialist focus on ME and be willing to fund speculative/risky pilot studies. (but obviously still science based)
Many of these studies will not get any substantial results, but this is how breakthroughs are made and how science progresses. Science is risky.
In other diseases, they have strong charity groups which fund pilot studies and researchers are also willing to borrow funding from other areas to fund pilot studies on the sly (yes this is corruption and it sucks that this is the norm - this is the main way researchers have to do risky studies, because it is so hard to get funding otherwise)
It is so sad that funding agencies don't understand the need - why funding (many) risky pilot studies will ultimately pay off in the end.
The big game changer is crowd funding. The CAA and now Solve-CFS focused their efforts on funding pilot studies with the hope that it would lead to researchers having preliminary evidence to apply for funding from other funding.
Just as important as the big studies (eg the Rituximab studies, or the microbiome project) are smaller pilot studies and potentially we could create our own crowdfunded organisation and review body to fund them. (optimistic, but there you go...)